SATRAPLATIN (S) INCREASES PROGRESSION-FREE SURVIVAL (PFS) AND DELAYS PAIN PROGRESSION IN PATIENTS (PTS) WITH HORMONE REFRACTORY PROSTATE CANCER (HRPC) THAT HAVE PROGRESSED AFTER PRIOR DOCETAXEL

✍ Scribed by N. Sternberg; O.A. Sartor; D.P. Petrylak; F. Witjes; I. Bodrogi; P. Harper; N. James; T. Demkov; J-C. Eymard; M. Wirth

• Book ID: 119618965
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 75 KB
• Volume: 7
• Category: Article
• ISSN: 1569-9056
• DOI: 10.1016/s1569-9056(08)60635-1